Paracetamol Baxter (Paracetamol)

Paracetamol works by inhibiting central cyclooxygenase enzymes, especially COX‑3, which lowers the production of prostaglandins in the brain and spinal cord. This reduction diminishes the perception of pain and resets the hypothalamic thermostat, resulting in analgesic and antipyretic actions.

The dose of Paracetamol Baxter is determined by the prescribing clinician based on the patient’s age, weight, clinical condition, and liver function. Healthcare professionals calculate the appropriate amount and infusion rate to achieve safe and effective analgesia or antipyresis.

Paracetamol Baxter falls under an unknown pregnancy category, so it should only be used during pregnancy or lactation when the potential benefit justifies any possible risk. The prescriber must evaluate maternal and fetal health before deciding to administer the product.

To order Paracetamol Baxter, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs) and the necessary import documentation.

Compared with non‑steroidal anti‑inflammatory drugs (NSAIDs) such as ibuprofen, Paracetamol Baxter offers analgesia and fever reduction without significant anti‑inflammatory activity or gastrointestinal irritation. Unlike opioids, it carries a lower risk of respiratory depression and dependence, but it requires careful monitoring of liver function, especially at high doses or with concurrent hepatotoxic agents.

Paracetamol Baxter should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. The vial must be kept upright, and any unused portion should be discarded according to local regulations after the recommended in‑use period.

Paracetamol Baxter is given by intravenous infusion. The solution is typically diluted in compatible IV fluid and administered over a short period, as directed by the prescriber. Administration should be performed by qualified healthcare personnel using aseptic technique to avoid contamination.

The most serious risks include acute liver failure, severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, and anaphylactic shock. Early signs of hepatic injury (e.g., jaundice, dark urine) or severe allergic response (e.g., rash, swelling, breathing difficulty) require immediate medical attention.

Paracetamol Baxter should be avoided in individuals with known hypersensitivity to paracetamol or any excipients, and in patients with severe hepatic impairment or active liver disease. Caution is also advised for patients taking multiple hepatotoxic drugs or those with a history of severe skin reactions to medications.